These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31646295)

  • 1. Cardiovascular disease in type 1 diabetes.
    Sharma H; Lencioni M; Narendran P
    Cardiovasc Endocrinol Metab; 2019 Mar; 8(1):28-34. PubMed ID: 31646295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease in type 1 diabetes: A review of epidemiological data and underlying mechanisms.
    Vergès B
    Diabetes Metab; 2020 Nov; 46(6):442-449. PubMed ID: 32998054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cardiovascular risk in adults with type 1 diabetes: poor concordance between the 2019 ESC risk classification and 10-year cardiovascular risk prediction according to the Steno Type 1 Risk Engine.
    Tecce N; Masulli M; Lupoli R; Della Pepa G; Bozzetto L; Palmisano L; Rivellese AA; Riccardi G; Capaldo B
    Cardiovasc Diabetol; 2020 Oct; 19(1):166. PubMed ID: 33010807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steno type 1 risk engine and preclinical atherosclerosis in Mediterranean individuals with type 1 diabetes.
    Viñals C; Conget I; Pané A; Boswell L; Perea V; Blanco AJ; Ruiz S; Giménez M; Vinagre I; Esmatjes E; Ortega E; Amor AJ
    Diabetes Metab Res Rev; 2020 Oct; 36(7):e3320. PubMed ID: 32239693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk.
    Serés-Noriega T; Giménez M; Perea V; Boswell L; Viñals C; Blanco J; Vinagre I; Pané A; Esmatjes E; Conget I; Amor AJ
    Diabetes Care; 2022 Oct; 45(10):2412-2421. PubMed ID: 35944257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of the Steno type 1 risk engine for cardiovascular disease prediction in Italian patients with type 1 diabetes.
    Boscari F; Morieri ML; Amato AML; Vallone V; Uliana A; Baritussio A; Vitturi N; Cipponeri E; Cavallin F; Avogaro A; Fadini GP; Bruttomesso D
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1813-1819. PubMed ID: 32807633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular or chronological age: which is the better marker to estimate the cardiovascular risk in patients with type 1 diabetes?
    de Andrade CRM; Silva ELC; da Matta MFB; Castier MB; Rosa MLG; Gomes MB
    Acta Diabetol; 2016 Dec; 53(6):925-933. PubMed ID: 27528365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambivalence about the selection of cardiovascular risk stratification tools: Evidence in a type 1 diabetes population.
    Bovi TG; Zantut-Wittmann DE; Parisi MCR
    Diabetes Metab Syndr; 2019; 13(3):2322-2327. PubMed ID: 31235175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Related Differences in Cardiovascular Disease Risk Profile in Children and Adolescents with Type 1 Diabetes.
    Smigoc Schweiger D; Battelino T; Groselj U
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced brachial artery distensibility in patients with type 1 diabetes.
    Ljunggren P; Maahs DM; Johansson P; Ludvigsson J; Pyle L; Sippl R; Wadwa RP; Snell-Bergeon J
    J Diabetes Complications; 2016 Jul; 30(5):893-7. PubMed ID: 27056753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influences of gender on cardiovascular disease risk factors in adolescents with and without type 1 diabetes.
    Brown TL; Maahs DM; Bishop FK; Snell-Bergeon JK; Wadwa RP
    Int J Pediatr Endocrinol; 2016; 2016():8. PubMed ID: 27099615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient's Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data.
    Šimonienė D; Platūkiene A; Prakapienė E; Radzevičienė L; Veličkiene D
    Diabetes Ther; 2020 Jan; 11(1):161-174. PubMed ID: 31792784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes.
    Dei Cas A; Aldigeri R; Mantovani A; Masulli M; Palmisano L; Cavalot F; Bonomo K; Baroni MG; Cossu E; Cavallo G; Cimini FA; Buzzetti R; Mignogna C; Leonetti F; Bacci S; Trevisan R; Morieri ML; Pollis RM; Targher G; Vigili de Kreutzenberg S
    J Clin Endocrinol Metab; 2023 Aug; 108(9):e789-e798. PubMed ID: 36881927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of cardiovascular autonomic neuropathy in patients with type 1 diabetes.
    Tannus LR; Drummond KR; Clemente EL; da Matta Mde F; Gomes MB;
    Front Endocrinol (Lausanne); 2014; 5():191. PubMed ID: 25505446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular function/dysfunction in adolescents with type 1 diabetes.
    Nadeau KJ; Reusch JE
    Curr Diab Rep; 2011 Jun; 11(3):185-92. PubMed ID: 21336845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrovascular angiopathy in children and adolescents with type 1 diabetes.
    Giannini C; Mohn A; Chiarelli F; Kelnar CJ
    Diabetes Metab Res Rev; 2011 Jul; 27(5):436-60. PubMed ID: 21433262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac autonomic function in children with type 1 diabetes.
    Metwalley KA; Hamed SA; Farghaly HS
    Eur J Pediatr; 2018 Jun; 177(6):805-813. PubMed ID: 29500542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population.
    Lee SI; Patel M; Jones CM; Narendran P
    Ther Adv Chronic Dis; 2015 Nov; 6(6):347-74. PubMed ID: 26568811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges and Opportunities in the Management of Cardiovascular Risk Factors in Youth With Type 1 Diabetes: Lifestyle and Beyond.
    Katz M; Giani E; Laffel L
    Curr Diab Rep; 2015 Dec; 15(12):119. PubMed ID: 26520142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyslipidaemia in Type 1 Diabetes: Molecular Mechanisms and Therapeutic Opportunities.
    O'Brien ST; Neylon OM; O'Brien T
    Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.